Business Description
U-Neuron Biomedical Inc
ISIN : TW0006973001
Description
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 54.96 | |||||
| Equity-to-Asset | 0.94 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.14 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 30.85 | |||||
| Beneish M-Score | -2.3 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 19.55 | |||||
| 9-Day RSI | 31.18 | |||||
| 14-Day RSI | 37.89 | |||||
| 6-1 Month Momentum % | -10.97 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 15.84 | |||||
| Quick Ratio | 15.44 | |||||
| Cash Ratio | 15.09 | |||||
| Days Inventory | 412.25 | |||||
| Days Sales Outstanding | 27.36 | |||||
| Days Payable | 102.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.33 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 76.6 | |||||
| Operating Margin % | -190.74 | |||||
| Net Margin % | -170.73 | |||||
| FCF Margin % | -260.51 | |||||
| ROE % | -12.44 | |||||
| ROA % | -11.81 | |||||
| ROIC % | -144.92 | |||||
| ROC (Joel Greenblatt) % | -247.34 | |||||
| ROCE % | -12.33 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 33.54 | |||||
| PB Ratio | 2.67 | |||||
| Price-to-Tangible-Book | 2.66 | |||||
| EV-to-EBIT | -18.79 | |||||
| EV-to-EBITDA | -21.4 | |||||
| EV-to-Revenue | 31.99 | |||||
| EV-to-FCF | -12.78 | |||||
| Price-to-Net-Current-Asset-Value | 3.14 | |||||
| Price-to-Net-Cash | 3.31 | |||||
| Earnings Yield (Greenblatt) % | -5.33 | |||||
| FCF Yield % | -6.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
U-Neuron Biomedical Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 35.823 | ||
| EPS (TTM) (NT$) | -1.498 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 37.89 | ||
| 14-Day ATR (NT$) | 0.46912 | ||
| 20-Day SMA (NT$) | 39.445 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (NT$) | 38 - 60.219236 | ||
| Shares Outstanding (Mil) | 39.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
U-Neuron Biomedical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
U-Neuron Biomedical Inc Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
U-Neuron Biomedical Inc Frequently Asked Questions
What is U-Neuron Biomedical Inc(ROCO:6973)'s stock price today?
The current price of ROCO:6973 is NT$38.90. The 52 week high of ROCO:6973 is NT$60.22 and 52 week low is NT$38.00.
When is next earnings date of U-Neuron Biomedical Inc(ROCO:6973)?
The next earnings date of U-Neuron Biomedical Inc(ROCO:6973) is .
Does U-Neuron Biomedical Inc(ROCO:6973) pay dividends? If so, how much?
U-Neuron Biomedical Inc(ROCO:6973) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers